Related references
Note: Only part of the references are listed.PEG shedding-rate-dependent blood clearance of PEGylated lipid nanoparticles in mice: Faster PEG shedding attenuates anti-PEG IgM production
Takuya Suzuki et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2020)
DAMP-sensing receptors in sterile inflammation and inflammatory diseases
Tao Gong et al.
NATURE REVIEWS IMMUNOLOGY (2020)
The efficiency of lipid nanoparticles with an original cationic lipid as a siRNA delivery system for macrophages and dendritic cells
Yasunori Uemura et al.
PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY (2019)
Epigenetic control of early dendritic cell lineage specification by the transcription factor IRF8 in mice
Daisuke Kurotaki et al.
BLOOD (2019)
Regulation and role of the transcription factor IRF5 in innate immune responses and systemic lupus erythematosus
Tatsuma Ban et al.
INTERNATIONAL IMMUNOLOGY (2018)
Patisiran, an RNAi Therapeutic, for Hereditary Transthyretin Amyloidosis
D. Adams et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Kupffer cell-derived TNF-α promotes hepatocytes to produce CXCL1 and mobilize neutrophils in response to necrotic cells
Li Su et al.
CELL DEATH & DISEASE (2018)
Organ-Specific Fate, Recruitment, and Refilling Dynamics of Tissue-Resident Macrophages during Blood-Stage Malaria
Si Min Lai et al.
CELL REPORTS (2018)
Granulocyte-Monocyte Progenitors and Monocyte-Dendritic Cell Progenitors Independently Produce Functionally Distinct Monocytes
Alberto Yanez et al.
IMMUNITY (2017)
Designing lipid nanoparticles for topical ocular drug delivery
Jesus Alvarez-Trabado et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2017)
Biodegradable lipid nanoparticles induce a prolonged RNA interference-mediated protein knockdown and show rapid hepatic clearance in mice and nonhuman primates
Yuta Suzuki et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2017)
Lipid Nanoparticle Systems for Enabling Gene Therapies
Pieter R. Cullis et al.
MOLECULAR THERAPY (2017)
Expanding the B Cell-Centric View of Systemic Lupus Erythematosus
Peter A. Morawski et al.
TRENDS IN IMMUNOLOGY (2017)
Pro-inflammatory hepatic macrophages generate ROS through NADPH oxidase 2 via endocytosis of monomeric TLR4-MD2 complex
So Yeon Kim et al.
NATURE COMMUNICATIONS (2017)
Transcriptome-based profiling of yolk sac-derived macrophages reveals a role for Irf8 in macrophage maturation
Nora Hagemeyer et al.
EMBO JOURNAL (2016)
Structure, activity and uptake mechanism of siRNA-lipid nanoparticles with an asymmetric ionizable lipid
Yuta Suzuki et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2016)
Delivery of siRNAs to Dendritic Cells Using DEC205-Targeted Lipid Nanoparticles to Inhibit Immune Responses
Joseph A. Katakowski et al.
MOLECULAR THERAPY (2016)
The development and maintenance of resident macrophages
Elisa Gomez Perdiguero et al.
NATURE IMMUNOLOGY (2016)
Systemic Gene Silencing in Primary T Lymphocytes Using Targeted Lipid Nanoparticles
Srinivas Ramishetti et al.
ACS NANO (2015)
Preclinical and clinical development of siRNA-based therapeutics
Gulnihal Ozcan et al.
ADVANCED DRUG DELIVERY REVIEWS (2015)
Most Tissue-Resident Macrophages Except Microglia Are Derived from Fetal Hematopoietic Stem Cells
Jianpeng Sheng et al.
IMMUNITY (2015)
Size-dependent specific targeting and efficient gene silencing in peritoneal macrophages using a pH-sensitive cationic liposomal siRNA carrier
Hideki Matsui et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2015)
siRNA-lipid nanoparticles with long-term storage stability facilitate potent gene-silencing in vivo
Y. Suzuki et al.
JOURNAL OF CONTROLLED RELEASE (2015)
The concanavalin A model of acute hepatitis in mice
F. Heymann et al.
LABORATORY ANIMALS (2015)
In Vivo Silencing of the Transcription Factor IRF5 Reprograms the Macrophage Phenotype and Improves Infarct Healing
Gabriel Courties et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2014)
Stabilization of Ostwald Ripening in Low Molecular Weight Amino Lipid Nanoparticles for Systemic Delivery of siRNA Therapeutics
Marian E. Gindy et al.
MOLECULAR PHARMACEUTICS (2014)
The function of Fcγ receptors in dendritic cells and macrophages
Martin Guilliams et al.
NATURE REVIEWS IMMUNOLOGY (2014)
Liposomal drug delivery systems: From concept to clinical applications
Theresa M. Allen et al.
ADVANCED DRUG DELIVERY REVIEWS (2013)
Pretreatment With TCDD Exacerbates Liver Injury From Concanavalin A: Critical Role for NK Cells
Aaron M. Fullerton et al.
TOXICOLOGICAL SCIENCES (2013)
Safety profile of RNAi nanomedicines
Scott A. Barros et al.
ADVANCED DRUG DELIVERY REVIEWS (2012)
Curcumin attenuates Concanavalin A-induced liver injury in mice by inhibition of Toll-like receptor (TLR) 2, TLR4 and TLR9 expression
Chuan-tao Tu et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2012)
Systemic RNAi-mediated Gene Silencing in Nonhuman Primate and Rodent Myeloid Cells
Tatiana I. Novobrantseva et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2012)
Interaction of Cholesterol-Conjugated Ionizable Amino Lipids with Biomembranes: Lipid Polymorphism, Structure-Activity Relationship, and Implications for siRNA Delivery
Jingtao Zhang et al.
LANGMUIR (2011)
Therapeutic siRNA silencing in inflammatory monocytes in mice
Florian Leuschner et al.
NATURE BIOTECHNOLOGY (2011)
MyD88-dependent pathway accelerates the liver damage of Concanavalin A-induced hepatitis
Keisuke Ojiro et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2010)
Targeted Delivery of RNAi Therapeutics With Endogenous and Exogenous Ligand-Based Mechanisms
Akin Akinc et al.
MOLECULAR THERAPY (2010)
Confirming the RNAi-mediated mechanism of action of siRNA-based cancer therapeutics in mice
Adam D. Judge et al.
JOURNAL OF CLINICAL INVESTIGATION (2009)
Mannosylated nanoparticulate carriers of rifabutin for alveolar targeting
Navneet Nimje et al.
JOURNAL OF DRUG TARGETING (2009)
Inflammatory Regulation by TLR3 in Acute Hepatitis
Xiaoyan Xiao et al.
JOURNAL OF IMMUNOLOGY (2009)
TLR-9 Activation Aggravates Concanavalin A-Induced Hepatitis via Promoting Accumulation and Activation of Liver CD4+ NKT Cells
Wei Jiang et al.
JOURNAL OF IMMUNOLOGY (2009)
Knocking down barriers: advances in siRNA delivery
Kathryn A. Whitehead et al.
NATURE REVIEWS DRUG DISCOVERY (2009)
The IRF family transcription factors in immunity and oncogenesis
Tomohiko Tamura et al.
ANNUAL REVIEW OF IMMUNOLOGY (2008)
Superoxide Produced by Kupffer Cells Is an Essential Effector in Concanavalin A-induced Hepatitis in Mice
Hiroyuki Nakashima et al.
HEPATOLOGY (2008)
Functional Regulation of MyD88-Activated Interferon Regulatory Factor 5 by K63-Linked Polyubiquitination
Mumtaz Yaseen Balkhi et al.
MOLECULAR AND CELLULAR BIOLOGY (2008)
Preclinical studies to understand nanoparticle interaction with the immune system and its potential effects on nanoparticle biodistribution
Marina A. Dobrovolskaia et al.
MOLECULAR PHARMACEUTICS (2008)
A combinatorial library of lipid-like materials for delivery of RNAi therapeutics
Akin Akinc et al.
NATURE BIOTECHNOLOGY (2008)
Time-dependent changes in opsonin amount associated on nanoparticles alter their hepatic uptake characteristics
Susumu Nagayama et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2007)
Paradoxical roles of the immune system during cancer development
KE de Visser et al.
NATURE REVIEWS CANCER (2006)
Cationic lipid saturation influences intracellular delivery of encapsulated nucleic acids
J Heyes et al.
JOURNAL OF CONTROLLED RELEASE (2005)
The interferon regulatory factor, IRF5, is a central mediator of toll-like receptor 7 signaling
A Schoenemeyer et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Integral role of IRF-5 in the gene induction programme activated by Toll-like receptors
A Takaoka et al.
NATURE (2005)
Colony-stimulating factor-1-dependent macrophages are responsible for IVIG protection in antibody-induced autoimmune disease
P Bruhns et al.
IMMUNITY (2003)
Size-dependent in vivo growth potential of adult rat hepatocytes
S Katayama et al.
AMERICAN JOURNAL OF PATHOLOGY (2001)
Importance of Kupffer cells for T-cell-dependent liver injury in mice
J Schümann et al.
AMERICAN JOURNAL OF PATHOLOGY (2000)
Critical contribution of liver natural killer T cells to a murine model of hepatitis
K Takeda et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Augmentation of Vα14 NKT cell-mediated cytotoxicity by interleukin 4 in an autocrine mechanism resulting in the development of concanavalin A-induced hepatitis
Y Kaneko et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2000)
Share Paper
